Highlights

  • XRF Scientific reported revenue of A$59.44 million and net profit of A$10.38 million for the latest reported financial year.
  • The company reported revenue growth during the March 2026 quarter and continued expansion in international operations.
  • XRF entered into an agreement to acquire Bruker's Combustion Gas Analysis (CGA) business, broadening its analytical instrument portfolio.
  • Management said it remains focused on international expansion, product development and evaluating merger and acquisition opportunities.

XRF Scientific Limited (ASX: XRF) operates within the Capital Goods industry, developing and supplying analytical equipment, consumables and related solutions for laboratory and industrial applications. The company serves customers across a range of sectors that require material analysis and sample preparation technologies.

This article reviews XRF Scientific's reported financial performance, historical revenue and net profit trend, and recent company announcements. It is based solely on the information provided and is intended for educational purposes only. It should not be considered financial or investment advice.

Financial Performance Overview

For the latest reported financial year, XRF Scientific reported revenue of A$59.44 million, net profit of A$10.38 million and earnings per share (EPS) of A$0.075.

Reviewing financial performance across multiple reporting periods provides additional context for understanding changes in the company's reported operations and financial results.

Revenue and Net Profit Trend

XRF Scientific's reported financial results show changes in revenue and continued growth in net profit across the four financial years presented.

For June 2022, the company reported revenue of A$40.00 million and net profit of A$6.08 million. In June 2023, revenue increased to A$55.26 million, while net profit was A$7.68 million.

For June 2024, XRF Scientific reported revenue of A$60.11 million and net profit of A$8.88 million. In the latest reported financial year ended June 2025, revenue was A$59.44 million, while net profit increased to A$10.38 million.

These figures provide a historical overview of the company's reported financial performance across recent financial years.

Recent Company Updates

In its March 2026 Quarterly Trading Update, released on 15 April 2026, XRF Scientific reported quarterly revenue of A$15.8 million, an increase of 13.8%, while profit before tax rose 10.7% to A$3.7 million. For the first nine months of FY2026, the company reported revenue of A$47.0 million, up 10.6%, and profit before tax of A$11.2 million, an increase of 8.5%.

The company stated that international sales, particularly across Asia, contributed to growth during the quarter. XRF also announced that its new office in India became operational during the period and received its first customer orders in March.

According to the company, demand continued across several product categories, including consumables, capital equipment, Orbis crushers, next-generation xrFuse products and xrTGA systems. Management also stated that it remains focused on expanding international sales, developing new products and evaluating merger and acquisition opportunities.

On 23 April 2026, XRF Scientific announced that it had entered into a binding agreement to acquire Bruker's Combustion Gas Analysis (CGA) business. The acquisition includes analytical instruments used to measure carbon, sulfur, oxygen, hydrogen and nitrogen across a range of industrial applications.

The company said the transaction will be funded from existing cash reserves, comprising an upfront payment of US$4 million and a potential earnout of up to US$1 million, subject to future revenue performance. XRF stated that the acquisition is expected to broaden its analytical instrument portfolio, diversify its exposure to additional industrial markets and create opportunities for additional consumable revenue. The company also plans to transfer production from Germany to its Perth facility as part of the transition process.

Industry Overview

XRF Scientific operates within the Capital Goods industry, which includes companies that manufacture equipment, industrial technologies and specialised machinery used across multiple sectors. Businesses in this industry often focus on product innovation, manufacturing capability and long-term customer relationships to support industrial operations.

Demand for analytical instruments and laboratory equipment can be influenced by activity across mining, manufacturing, research, environmental testing and other industries that require material analysis and quality control.

Understanding the Latest Developments

The company's recent updates highlight two areas of focus: operational expansion and portfolio development. The March 2026 trading update outlined continued business activity across several product categories and international markets, while the proposed acquisition is intended to expand XRF Scientific's product offering and operational capabilities.

Together with the company's reported financial results, these developments provide additional context for understanding its reported business activities.

Conclusion

XRF Scientific Limited's reported financial performance and recent announcements provide an overview of its operations, business expansion initiatives and acquisition strategy. The company's latest updates include continued international expansion, product development activities and the planned acquisition of Bruker's Combustion Gas Analysis business.

This article is based solely on the information provided and is intended for educational and informational purposes only. It should not be considered financial or investment advice.